The medical and diagnostic division of the Japanese technology giant, Canon, has won the contract to set up magnetic resonance imaging equipment in Albacete for $1.02 million (€900,000), according to the profile of the community contractor.
Canon Medical Systems will be responsible for the supply, work, installation and commissioning and maintenance of a magnetic resonance imaging system at the Villarrobledo Hospital, which belongs to the Castilla-La Mancha Health Service.
If you want to find more details about the latest contract signed by Canon to install a new magnetic resonance imaging system in Albacete, Spain, and to read the latest business headlines in the world, download for free the Born2Invest mobile app.
The contract between Canon and the Villarrobledo Hospital can be extended
The contract is for a period of four years, with an option to extend it by two years. It includes the renovation and adaptation of some spaces on the first floor of the hospital, integrated within the radiodiagnosis service, for the location of the technical room, examination room, magnetic resonance equipment control room, and waiting rooms.
According to the document signed by the director-general of health care of the Government of Castilla-La Mancha, José Antonio Ballesteros, and taking into consideration market studies carried out and taking into account the latest awards of this health service for equipment of the same characteristics “the appropriate price is around $670,000 (€590,000).” Finally, the total amount for the equipment alone is just over $605,700 (€532,000) and payment is made in 2020.
Canon will carry out around 5,000 tests a year at the Albacete hospital
The price for the maintenance of the medical equipment is more than $180,000 (€158,000). The first payment will be made in 2021 and will amount to $40,120 (€35,225). In 2022 and 2023 the payments will be approximately $60,000 (€53,000), while in 2024 the amount will be $20,000 (€17,600). As for the adaptation works, a payment will be made this year of approximately $206,000 (€181,000).
Canon has been chosen over Philips as it has obtained a final score of 81.2 points, according to the Regional Executive, which has assessed the economic proposals of the equipment, the works and their subsequent maintenance. “The company has submitted the best offer in terms of quality/price ratio in accordance with article 145 of the Public Sector Contracts Law,” the autonomous government has pointed out.
The new magnetic resonance imaging system will carry out around 5,000 tests a year, which will make it possible to cover the demand of the population in that healthcare area. In this way, patients in the region will not have to travel to other hospitals such as those in Albacete, Alcázar de San Juan, or Tomelloso, the latter being the center where most of these tests have been carried out. Canon Medical Systems offers a wide range of diagnostic imaging equipment including CT, X-ray, ultrasound, and MRI.
From December 2016, Canon Medical became a member of the Canon Group, as it was previously an independent company. Since April, the chairmanship of Canon Medical Systems in Europe has been held by Nobuyuki Hatakeyama, following the resignation of Mark Holmshaw, former CEO for the European market, who now holds the position of consultant.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Roche signs its new diabetes business manager in Spain to Isdin
The company Roche Diabetes Care Spain, part of the Swiss pharmaceutical group, has appointed Josep Maria Vallmajó to hold the...
Major reasons why your website might not be attracting customers
In 2016, the number of business websites had almost doubled from 900 million to nearly 1.7 billion. Whatever your marketing...
Savills IM refinances two Italian assets with one of the first green loans in Italy
One of the first green loans in Italy will refinance the retail park in Fidenza (Parma) and the U4 office...
4 tips to market your small business locally
Whether you’ve recently started a small business or have pivoted your sales tactics for your company because of COVID-19, you’re...
Bitcoin revolution by integration with PayPal
The integration of Bitcoin with PayPal is probably one of the most important news for the entire crypto industry in...
Africa5 days ago
Why countries in southern Africa could become leaders in the cannabis sector
Featured6 days ago
How the coronavirus pandemic impacted the German Fintech sector
Featured6 days ago
Why is the stock market up?
Featured6 days ago
What’s the problem with the Dow Jones? Maybe it’s overvalued